 The NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia (T-ALL) has recently been identified as a possible target for imatinib and related tyrosine kinase inhibitors, but exact data regarding the prognostic impact and frequency of the several putative NUP214-ABL1 mRNA transcripts are still missing.     ///    "Based on the results, we have established and tested a novel PCR method for simplified detection of the NUP214-ABL1 fusion gene.. "    ///    "Eleven (3.9%) patients were NUP214-ABL1 positive, and 5 different transcripts were observed. "    ///    NUP214-ABL1 in adult T-ALL: the GMALL study group experience..     ///    "We investigated 279 adult patients with T-ALL treated within the framework of the GMALL 5/93 and 6/99 therapy trials for NUP214-ABL1 by using a novel multiplex real-time, quantitative polymerase chain reaction (PCR). "